Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Cancer|April 15, 1982
Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and bloodA A Bom-Van Noorloos, A A Van Beek, J Ubels-Postma, et al.
European Journal of Immunology|December 1, 1993
Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processingM A Ossevoort, A J Sijts, K J van Veen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Lysis of syngeneic tumor B cells by autoreactive cytotoxic T lymphocytes specific for a CD19 antigen-derived synthetic peptideE Hooijberg, M J Visseren, P C van den Berk, et al.
The Journal of Endocrinology|April 9, 1999
Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritisA M ten Bokum, E G Lichtenauer-Kaligis, M J Melief, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 3, 2001
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancerH W Nijman, P J van Diest, R J Poort-Keesom, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumorsJ P Medema, J de Jong, L T Peltenburg, et al.
Clinical and Experimental Immunology|March 1, 1982
T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cellsS L Thien, D Catovsky, D Oscier, et al.
The Journal of Experimental Medicine|July 1, 1995
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cellsH W Nijman, M J Kleijmeer, M A Ossevoort, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
Pageof 34